Trial | NCT01708538  Report issue

Title

The Effects of Corneal Collagen Cross-linking
Phase III Study of Corneal Collagen Cross-linking Using Two Different Techniques.

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Recruiting

  • Study Participants

    30
The corneal collagen cross-linking treatment has been used with increasing success to treat corneal dystrophies such as "keratoconus." Recent advances have allowed different techniques for performing this cross-linking treatment. This study investigates the effects of corneal cross-linking using different surgical techniques.
Study Started
Oct 31
2012
Primary Completion
Oct 31
2024
Anticipated
Study Completion
Oct 31
2024
Anticipated
Last Update
Oct 26
2022

Drug CXL

corneal crosslinking

Epithelium on Active Comparator

Epi not removed during CXL treatment

Epithelium off Active Comparator

Epi removed before CXL treatment

Criteria 

Inclusion Criteria:

Age 10-70, willing to participate, diagnosis of corneal ectasia disorder

Exclusion Criteria:

Unwilling or unable to participate in trial
No Results Posted